Similar articles for PMID: 21590281

Year	Number of Results
1994	1
1995	1
1996	3
1997	2
1998	4
1999	1
2000	6
2001	2
2002	1
2003	5
2004	1
2005	7
2006	2
2007	7
2008	7
2009	3
2010	4
2011	15
2012	15
2013	17
2014	6
2015	3
2016	7
2017	10
2018	11
2019	5
2020	5
2021	5
2022	13
2023	9
2024	0

1

Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia.

Roser P, Haussleiter IS, Chong HJ, Maier C, Kawohl W, Norra C, Juckel G. Roser P, et al. Psychopharmacology (Berl). 2011 Dec;218(4):611-20. doi: 10.1007/s00213-011-2352-y. Epub 2011 May 18. Psychopharmacology (Berl). 2011. PMID: 21590281 Clinical Trial.

2

Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.

Umbricht D, Schmid L, Koller R, Vollenweider FX, Hell D, Javitt DC. Umbricht D, et al. Arch Gen Psychiatry. 2000 Dec;57(12):1139-47. doi: 10.1001/archpsyc.57.12.1139. Arch Gen Psychiatry. 2000. PMID: 11115327

3

Glutamatergic deficit and schizophrenia-like negative symptoms: new evidence from ketamine-induced mismatch negativity alterations in healthy male humans.

Thiebes S, Leicht G, Curic S, Steinmann S, Polomac N, Andreou C, Eichler I, Eichler L, Zöllner C, Gallinat J, Hanganu-Opatz I, Mulert C. Thiebes S, et al. J Psychiatry Neurosci. 2017 Jun;42(4):273-283. doi: 10.1503/jpn.160187. J Psychiatry Neurosci. 2017. PMID: 28556775 Free PMC article. Clinical Trial.

4

The effects of ketamine on the mismatch negativity (MMN) in humans - A meta-analysis.

Rosburg T, Kreitschmann-Andermahr I. Rosburg T, et al. Clin Neurophysiol. 2016 Feb;127(2):1387-1394. doi: 10.1016/j.clinph.2015.10.062. Epub 2015 Nov 23. Clin Neurophysiol. 2016. PMID: 26699665

5

Glutamatergic modulation of auditory information processing in the human brain.

Gunduz-Bruce H, Reinhart RM, Roach BJ, Gueorguieva R, Oliver S, D'Souza DC, Ford JM, Krystal JH, Mathalon DH. Gunduz-Bruce H, et al. Biol Psychiatry. 2012 Jun 1;71(11):969-77. doi: 10.1016/j.biopsych.2011.09.031. Epub 2011 Oct 29. Biol Psychiatry. 2012. PMID: 22036036 Free PMC article. Clinical Trial.

6

Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.

Heekeren K, Daumann J, Neukirch A, Stock C, Kawohl W, Norra C, Waberski TD, Gouzoulis-Mayfrank E. Heekeren K, et al. Psychopharmacology (Berl). 2008 Jul;199(1):77-88. doi: 10.1007/s00213-008-1129-4. Epub 2008 May 18. Psychopharmacology (Berl). 2008. PMID: 18488201 Free PMC article. Clinical Trial.

7

NMDA Receptor Antagonist Effects on Speech-Related Mismatch Negativity and Its Underlying Oscillatory and Source Activity in Healthy Humans.

de la Salle S, Shah D, Choueiry J, Bowers H, McIntosh J, Ilivitsky V, Knott V. de la Salle S, et al. Front Pharmacol. 2019 May 8;10:455. doi: 10.3389/fphar.2019.00455. eCollection 2019. Front Pharmacol. 2019. PMID: 31139075 Free PMC article.

8

Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.

Hamilton HK, D'Souza DC, Ford JM, Roach BJ, Kort NS, Ahn KH, Bhakta S, Ranganathan M, Mathalon DH. Hamilton HK, et al. Schizophr Res. 2018 Jan;191:87-94. doi: 10.1016/j.schres.2017.06.040. Epub 2017 Jul 12. Schizophr Res. 2018. PMID: 28711472 Free PMC article. Clinical Trial.

9

Effect of ketamine on the neuromagnetic mismatch field in healthy humans.

Kreitschmann-Andermahr I, Rosburg T, Demme U, Gaser E, Nowak H, Sauer H. Kreitschmann-Andermahr I, et al. Brain Res Cogn Brain Res. 2001 Aug;12(1):109-16. doi: 10.1016/s0926-6410(01)00043-x. Brain Res Cogn Brain Res. 2001. PMID: 11489614

10

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS. Krystal JH, et al. Arch Gen Psychiatry. 1994 Mar;51(3):199-214. doi: 10.1001/archpsyc.1994.03950030035004. Arch Gen Psychiatry. 1994. PMID: 8122957 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

145 results

Results by year